This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Helena Dennison: Innovator in Hepatitis C Treatment
Introduction
Helena Dennison is a prominent inventor based in London, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for hepatitis C infection. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving healthcare.
Latest Patents
Helena Dennison holds a patent for "Benzodiazepine derivatives for treating hepatitis C infection." This patent involves the use of a benzodiazepine of a specific formula in the manufacture of a medicament aimed at treating or preventing hepatitis C infection. The patent details various chemical structures and functional groups that enhance the efficacy of the treatment.
Career Highlights
Throughout her career, Helena has been associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.
Collaborations
Helena has worked alongside notable colleagues such as Justin Warne and Keith Spencer. Their combined expertise has fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.
Conclusion
Helena Dennison's contributions to the field of hepatitis C treatment through her innovative patent exemplify her commitment to improving patient outcomes. Her work continues to inspire future advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile